MINAPHARM Pharmaceuticals (EGX: MIPH)

Market Cap	2.08B
Revenue (ttm)	3.92B
Net Income (ttm)	-273.19M
Shares Out	11.06M
EPS (ttm)	-24.69
PE Ratio	n/a
Forward PE	n/a
Dividend	1.65 (0.88%)
Ex-Dividend Date	n/a

Volume	967
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	145.01 - 294.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, medical and dental supplies, and dietary supplements in Egypt and internationally. The company produces veterinary and herbal medicines. It offers its products for the treatment of hematoma and thrombosis, iron deficiency anemia, recurrent urinary tract infections, immunostimulants, osteoporosis, renal osteodystrophy, loop diuretics, prophylaxis, hemorrhoids, rheumatoid arthritis, hyperlipidemia, alopecia, skin infections, topical corticosteroids, gynecological antifungals, vaginal infections, anti-...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 450
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MIPH